Industry: Pharmaceuticals, Biotechnology
Amyris Biotechnologies is focused on translating the promise of synthetic biology into solutions for real-world problems. Applying advances in molecular biology and chemistry, we have engineered microbes capable of cost-effectively producing high-value, complex molecules that are currently available only in small quantities through extraction from natural resources. We are employing these living microbial chemical factories to produce new pharmaceuticals, specialty chemicals, and biofuels. What’s New: October 12, 2006 — AMYRIS BIOTECHNOLOGIES RAISES $20 MILLION IN SERIES A FUNDING; APPOINTS JOHN G. MELO CHIEF EXECUTIVE OFFICER – Synthetic Biology Pioneer Expands into Bioenergy Field ( www.amyrisbiotech.com )
Amyris Biotechnologies Inc
5980 Horton Street Suite 450
Emeryville, California 94608
USA
Tel: (510) 450-0761
Fax: (510) 450-0794